BTIG Maintains Buy on OrthoPediatrics, Raises Price Target to $40

Benzinga · 2d ago
BTIG analyst Ryan Zimmerman maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and raises the price target from $30 to $40.